Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination dietary supplement containing three active ingredients: - **Coenzyme Q10 (ubidecarenone, CoQ10):** A lipid-soluble antioxidant and essential cofactor in mitochondrial oxidative phosphorylation, supporting cellular energy production and protecting cells from oxidative damage. It is commonly used as a supplement for cardiovascular health, mitochondrial disorders, and as an antioxidant[5][7]. - **Sodium ferrous citrate:** An iron salt used to treat or prevent iron deficiency anemia by providing bioavailable iron necessary for hemoglobin synthesis. - **Vitamin B6 (pyridoxine):** A water-soluble vitamin involved in amino acid metabolism, neurotransmitter synthesis (including serotonin and dopamine), hemoglobin formation, immune function modulation, and reduction of homocysteine levels[4][8][6]. The combination has been studied for potential benefits in improving mental status in Alzheimer's disease[1][2], enhancing immune responses[3], and addressing nutritional deficiencies. Each component acts through distinct mechanisms—energy metabolism (CoQ10), hematopoiesis (iron), and enzymatic cofactor activity/neurotransmitter synthesis (vitamin B6).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on coenzyme Q10 + sodium ferrous citrate + vitamin B6.